Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

LEVOPHED DIN 02241981

Status: Cancelled Post Market
Holder: PFIZER CANADA ULC
Molecule: NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)
Available to quote

Health Canada record

Active ingredient(s)NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MG
Dosage formSolution
RouteIntravenous
ScheduleETHICAL
ClassHuman
ATCC01CA03 NOREPINEPHRINE
Original market date01-Oct-2001
Current status date31-Oct-2024
SourceHealth Canada DPD

Establishment licence of the holder

Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)

DINProductCompanyFormStrengthStatus
02501430NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTIONBAXTER CORPORATIONSolutionNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 0.016 MGMarketed
02501449NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTIONBAXTER CORPORATIONSolutionNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 0.032 MGMarketed
02540630NOREPINEPHRINE BITARTRATE INJECTIONJUNO PHARMACEUTICALS CORP.SolutionNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MGMarketed
02538857NOREPINEPHRINE BITARTRATE INJECTIONAS KALCEKSSolutionNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MGApproved
00893285NOREPINEPHRINE BITARTRATE INJECTION USPSANDOZ CANADA INCORPORATEDSolutionNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MGMarketed
02358743NOREPINEPHRINE BITARTRATE INJECTION, USPSTERIMAX INCSolutionNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MGMarketed
02017679LEVOPHED LIQ IV 1.0MG/MLSANOFI CANADA, INC.LiquidNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MGCancelled Post Market
02485680NOREPINEPHRINE BITARTRATE INJECTION USPGENERIC MEDICAL PARTNERS INCSolutionNOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) 1 MGDormant
Request a quote for LEVOPHED

How to read a Canadian DIN record